David Wurtman - Oct 13, 2021 Form 3 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role: Chief Medical Officer
Signature: David Wurtman
Stock symbol: LUCD
Transactions as of: Oct 13, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/13/2021, 09:28 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	LUCD	Employee stock option (right to buy)							Oct 13, 2021	Common stock	706K	$0.71	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options consist of: (i) 423,300 options granted February 18, 2019, 282,200 vesting upon grant and the rest vesting in twelve equal quarterly installments from March 31, 2019 to December 31, 2021, all 423,300 expiring February 18, 2029; and (ii) 282,200 options granted August 19, 2019, vesting in twelve equal quarterly installments from September 30, 2019 to June 30, 2022, and expiring August 19, 2029.

Content

These options consist of: (i) 423,300 options granted February 18, 2019, 282,200 vesting upon grant and the rest vesting in twelve equal quarterly installments from March 31, 2019 to December 31, 2021, all 423,300 expiring February 18, 2029; and (ii) 282,200 options granted August 19, 2019, vesting in twelve equal quarterly installments from September 30, 2019 to June 30, 2022, and expiring August 19, 2029.